Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Magn Reson Chem ; 43(9): 762-70, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16049946

RESUMO

High-performance liquid chromatography-solid phase extraction-NMR spectroscopy (HPLC-SPE-NMR) has recently become commercially available and has been evaluated with regard to its applicability in a pharmaceutical environment. The addition of an automated SPE unit to an HPLC-NMR system for peak trapping results in an improved NMR signal-to-noise ratio (S/N) and also has other practical advantages. The trapping efficiency is shown to depend on compound polarity and is highest for compounds eluting late on reversed-phase HPLC systems. Multiple peak trapping further increases the S/N, again with the best results for less polar compounds. For polar compounds, multiple peak trapping resulted in no S/N gain as the amount of material retained on the SPE cartridge was equivalent to that from a single injection. When compared with conventional HPLC-NMR, a S/N gain of up to five-fold could be achieved for some compounds in a single trapping step. A major advantage of the technique is the independence of the chromatographic step from the NMR step, resulting in greater versatility than conventional HPLC-NMR in the HPLC solvents and NMR solvents that can be used. Practical applications from both drug metabolite and drug impurity identification are presented.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Espectroscopia de Ressonância Magnética/métodos , Preparações Farmacêuticas/análise , Acetonitrilas/química , Ácidos Carbocíclicos/análise , Ácidos Carbocíclicos/química , Animais , Bile/química , Bile/metabolismo , Cães , Cetonas/análise , Cetonas/química , Preparações Farmacêuticas/química , Ratos , Sensibilidade e Especificidade , Solventes/química
2.
Bioorg Med Chem Lett ; 15(3): 737-41, 2005 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-15664848

RESUMO

Starting from a high throughput screening hit, a series of 3,4-dihydro-2H-benzoxazinones has been identified with both high affinity for the 5-HT(1A) receptor and potent 5-HT reuptake inhibitory activity. The 5-(2-methyl)quinolinyloxy derivative combined high 5-HT(1A/1B/1D) receptor affinities with low intrinsic activity and potent inhibition of the 5-HT reuptake site (pK(i)8.2). This compound also had good oral bioavailability and brain penetration in the rat.


Assuntos
Benzoxazinas/síntese química , Inibidores Seletivos de Recaptação de Serotonina/síntese química , Antagonistas do Receptor 5-HT1 de Serotonina , Animais , Benzoxazinas/farmacologia , Disponibilidade Biológica , Encéfalo/metabolismo , Linhagem Celular , Estabilidade de Medicamentos , Humanos , Ensaio Radioligante , Ratos , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Relação Estrutura-Atividade , Sinaptossomos/metabolismo
3.
J Chromatogr A ; 1028(2): 259-66, 2004 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-14989479

RESUMO

In combining the high peak concentrations of capillary liquid chromatography (CapLC) with the high mass sensitivity of micro scale nuclear magnetic resonance (NMR) the hyphenation of CapLC to micro NMR offers a substantial gain in overall sensitivity. This paper deals with our experiences gained using a commercial CapLC-NMR system which has very recently become available. The limits of detection (SNR > 3) for a test compound of a molecular weight of M 318 were found to be approximately 100 ng (0.35 nmol) within an hour acquisition time and approximately 25 ng over night (85 pmol). Practical aspects such as the feasibility of stopped-flow experiments and sample handling issues are discussed in detail and first possible drug metabolite applications to hepatocyte incubations and direct analysis of plasma samples are presented.


Assuntos
Cromatografia Líquida/métodos , Espectroscopia de Ressonância Magnética/métodos , Preparações Farmacêuticas/metabolismo , Animais , Anti-Inflamatórios não Esteroides/análise , Anti-Inflamatórios não Esteroides/sangue , Anti-Inflamatórios não Esteroides/metabolismo , Biotransformação , Diclofenaco/análise , Diclofenaco/sangue , Diclofenaco/metabolismo , Glucuronídeos/análise , Glucuronídeos/sangue , Hepatócitos/metabolismo , Sistemas On-Line , Preparações Farmacêuticas/química , Ratos , Espectrofotometria Ultravioleta , Viscosidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA